If you have a glass-half-full perspective, then the court's ruling to deny the proposed preliminary injunction to the Express Scripts-Medco marriage means none of this is over.
Generic drug maker Teva Pharmaceutical Industries and subsidiary Barr Labs are prohibited from marketing a generic version of an Amgen drug for patients with chronic kidney disease until the drug’s patents expire, under a recent court decision.